BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32210559)

  • 1. Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method.
    Yang G; Li Z; Wu F; Chen M; Wang R; Zhu H; Li Q; Yuan Y
    Int J Nanomedicine; 2020; 15():1661-1675. PubMed ID: 32210559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design:
    Musallam AA; Mahdy MA; Elnahas HM; Aldeeb RA
    Drug Deliv; 2022 Dec; 29(1):1582-1594. PubMed ID: 35612286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
    Li Z; Zhang Y; Zhang K; Wu Z; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of a new platform based on fumed and mesoporous silica nanoparticles for enhanced solubility and oral bioavailability of raloxifene HCl.
    Varshosaz J; Dayani L; Chegini SP; Minaiyan M
    IET Nanobiotechnol; 2019 Jun; 13(4):392-399. PubMed ID: 31171744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, Characterization, and Evaluation of Mesoporous Silica Nanoparticles in Enhancing Oral Bioavailability of Poorly Water-Soluble Drugs.
    Zhang H; Zuo F; Wang B; Qiu X
    Curr Drug Deliv; 2024 Jan; ():. PubMed ID: 38310438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel IMB16-4 Compound Loaded into Silica Nanoparticles Exhibits Enhanced Oral Bioavailability and Increased Anti-Liver Fibrosis In Vitro.
    Niu X; Wang X; Niu B; Li G; Yang X; Wang Y; Li G
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
    Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N
    Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of supercritical fluid technology for solid dispersion to enhance solubility and bioavailability of poorly water-soluble drugs.
    Tran P; Park JS
    Int J Pharm; 2021 Dec; 610():121247. PubMed ID: 34740762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed polyethylene glycol-modified breviscapine-loaded solid lipid nanoparticles for improved brain bioavailability: preparation, characterization, and in vivo cerebral microdialysis evaluation in adult Sprague Dawley rats.
    Liu Z; Okeke CI; Zhang L; Zhao H; Li J; Aggrey MO; Li N; Guo X; Pang X; Fan L; Guo L
    AAPS PharmSciTech; 2014 Apr; 15(2):483-96. PubMed ID: 24482026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
    Biswas N
    Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro/in vivo Evaluation of Lacidipine by Adsorption onto Fumed Silica Using Supercritical Carbon Dioxide.
    Geng Y; Fu Q; Guo B; Li Y; Zhang X; Wang X; Zhang T
    Curr Drug Deliv; 2016; 13(7):1053-1064. PubMed ID: 26634790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol.
    Han C; Huang H; Dong Y; Sui X; Jian B; Zhu W
    Molecules; 2019 May; 24(9):. PubMed ID: 31067732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.
    Rashid R; Kim DW; Yousaf AM; Mustapha O; Fakhar Ud Din ; Park JH; Yong CS; Oh YK; Youn YS; Kim JO; Choi HG
    Int J Nanomedicine; 2015; 10():6147-59. PubMed ID: 26491288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impregnation of mesoporous silica with poor aqueous soluble molecule using pressurized carbon dioxide: Is the solubility in the supercritical and subcritical phase a critical parameter?
    Koch N; Jennotte O; Grignard B; Lechanteur A; Evrard B
    Eur J Pharm Sci; 2020 Jul; 150():105332. PubMed ID: 32361178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
    Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
    Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.